What Is Rett Syndrome?
Rett syndrome is a genetic neurodevelopmental disorder most often caused by changes in the MECP2 gene. Many children appear to develop relatively typically at first, then lose skills or slow in development. Symptoms can include loss of purposeful hand use, distinctive hand movements, communication challenges, seizures, breathing irregularities, movement difficulties, sleep problems, and gastrointestinal issues.
Plain-English explanation
Rett syndrome is a genetic neurodevelopmental disorder most often caused by changes in the MECP2 gene. Many children appear to develop relatively typically at first, then lose skills or slow in development. Symptoms can include loss of purposeful hand use, distinctive hand movements, communication challenges, seizures, breathing irregularities, movement difficulties, sleep problems, and gastrointestinal issues.
Why it matters
Rett syndrome has become one of the most closely watched rare disease fields because families, foundations, and scientists have built a focused therapeutic roadmap. It also teaches a broader lesson: knowing the gene is only the beginning. Researchers still have to understand timing, dosage, brain delivery, safety, and which outcomes matter most.
How it works
MECP2 helps regulate gene expression in brain cells. Too little or too much MECP2 activity can cause problems, which makes treatment design delicate. Research strategies include gene therapy, RNA-based approaches, small molecules, and symptom-targeted care. Any disease-modifying therapy has to balance restoring function with avoiding overexpression or unintended effects.
Key terms
Related interviews and articles
Newborn Genome Screening Is Here: GUARDIAN, Rett & Rare Disease | Dr. Wendy Chung
Dr. Wendy Chung
“In one week I diagnosed a 72-year-old with Rett syndrome and a three-week-old with Rett syndrome.” Newborn genome sequencing isn’t science fiction anymore. It’s already changing which babies get diagnosed, when they get treated, and how...
Inside the Fight to Cure Rett Syndrome – Monica Coenraads Interview
Monica Coenraads
Monica Coenraads, founder and CEO of the Rett Syndrome Research Trust (RSRT), has led the charge to cure Rett Syndrome—raising over $123 million and driving multiple gene therapy programs now in clinical trials. In this in-depth conversa...